Point-of-Care Genetic Testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Product type and by End-Users : Opportunity Analysis and Industry Forecast, 2023-2032

The Point-of-care genetic testing market is analyzed at a global, regional, and country levels providing analysis of different segments divided depending on its characteristics such as by Product type, by End-Users.

Point-of-care genetic testing market Overview

The scope of the report focuses on the qualitative analysis covering drivers, opportunities, challenges, and trends. In addition, it emphasizes on the key strategies adopted by the players. Moreover, the major players operating in the market have been profiled in the report along with their strategic developments, including acquisitions, mergers, products launch, agreements, partnerships, collaborations, joint ventures, research & development investment, and regional expansion of leading companies operating in the market at global and regional levels.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers, And Impact Analysis

Increase/decline that is witnessed in the demand for Point-of-care genetic testing market has been analyzed in the study. In addition, the impact of cost on the market growth/decline has been studied and elaborated. Moreover, a cumulative effect of the potential factors are likely to expose a few niche market opportunities that can be capitalized by companies across the globe.

Key companies identified in the report include Illumina Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, PacGene, Sequenom Inc., Agilent Technologies Inc., QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Myriad Genetics, Inc.

Key Reasons to Buy the Report

1. Major region/country level quantitative and qualitative analysis

2. Detailed segment analysis at country level

3. Key supplier profiling and market share analysis

Free 20% customization and post-sales support

  Point-of-Care Genetic Testing Market Report Highlights

Aspects	Details
By Product type	Sequencing Diagnostics Pharmaceuticals Instruments and Equipment
By End-Users	Hospitals and Clinics Diagnostic Laboratories Research Institutes
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Cepheid, Thermo Fisher Scientific Inc., PacGene, Hologic, Myriad Genetics, Illumina Inc., QIAGEN N.V., Roche Diagnostics, Agilent Technologies Inc., Sequenom Inc.

^*Terms and Conditions Apply